About this trial
This comparative controlled clinical study aims to evaluate and compare the effectiveness of piezocision and low-level laser therapy (LLLT) as adjunctive interventions to accelerate orthodontic canine retraction. Participants will be randomly assigned to one of three groups: piezocision, LLLT, or a control group (no adjunctive procedure). The study will assess the impact of these interventions on the rate of tooth movement, the type of tooth movement, and patient experience.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Age range 18-25 years.
Patients with crowding or protrusion requiring at least bilateral maxillary first premolar extraction followed by symmetrical canine retraction.
Full set of permanent dentition (third molar not considered).
Patients with good oral hygiene.
Disqualifiers
Previous orthodontic treatment.
Patients taking medications or suffering from systemic conditions that can affect orthodontic tooth movement.
Active periodontal diseases and/or untreated carious lesions.
Congenital orofacial deformities.
Trial design
Parallel
Treatments tested in this trial
Low Level Laser Therapy
Procedure/SurgeryOn both right and left sides, LLLT will be performed at the beginning of canine retraction, after 3, 7, 14 days, and then every 14 days for a total four-month period.
Piezocision
Procedure/SurgeryOn both right and left sides, a minimally invasive flapless piezocision procedure will be performed each month from the beginning of the canine retraction for a total four-month period.
Treatment groups
Trial outcomes
Primary outcomes
Rate of canine retraction
The rate of distal movement of the maxillary canine measured in millimeters per month (mm/month).
Secondary outcomes
Maxillary canine rotation and tipping.
Measured in degrees
Maxillary first molar mesial movement
Maxillary first molar mesial movement (measured in mm)
Maxillary first molar rotatiob
(measured in degrees).
Patient-Reported Pain Intensity
Pain intensity will be measured using a 10-centimeter Visual Analogue Scale (VAS). The scale ranges from 0 to 10, where 0 represents "no pain" and 10 represents "the worst possible pain" . Therefore, higher scores indicate a worse outcome (greater pain intensity).
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Hesham Nabil Ali Al-Qamhawy
Lead sponsor
Al-Azhar University
Sponsor institution
Al-Azhar University
Collaborator